StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) stock

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/302% above fair value
$14.35+0.29 (+2.06%)

Close on Nov 20, 2026Market cap $285.81MP/E 35.0Yield –

InfuSystem free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

InfuSystem's free cash flow for the twelve months ending Jun 30, 2026 was $22.91M, down 10.7% year over year. For fiscal 2025 it was $23.85M, up 23.1% from the year before. Over ten years it grew 13.5% a year on average. The highest annual figure on record is $23.85M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$23.85M+23.1%
FY2024Dec 31, 2024$19.37M+89.9%
FY2023Dec 31, 2023$10.20M-38.3%
FY2022Dec 31, 2022$16.54M-4.6%
FY2021Dec 31, 2021$17.34M-9.6%
FY2020Dec 31, 2020$19.19M+75.2%
FY2019Dec 31, 2019$10.95M-1.4%
FY2018Dec 31, 2018$11.11M+45.9%
FY2017Dec 31, 2017$7.61M-1.6%
FY2016Dec 31, 2016$7.74M+14.9%
FY2015Dec 31, 2015$6.74M+28.1%
FY2014Dec 31, 2014$5.26M+92.0%
FY2013Dec 31, 2013$2.74M–
FY2012Dec 31, 2012-$1.09M–
FY2011Dec 31, 2011-$1.47M-117.5%
FY2010Dec 31, 2010$8.37M+64.2%
FY2009Dec 31, 2009$5.10M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.69M-1.6%
Q1 FY2026Mar 31, 2026$813.00K-50.7%
Q4 FY2025Dec 31, 2025$6.99M-5.5%
Q3 FY2025Sep 30, 2025$8.41M-14.1%
Q2 FY2025Jun 30, 2025$6.79M+244.4%
Q1 FY2025Mar 31, 2025$1.65M+745.6%
Q4 FY2024Dec 31, 2024$7.40M+74.1%
Q3 FY2024Sep 30, 2024$9.80M+136.6%
Q2 FY2024Jun 30, 2024$1.97M-13.3%
Q1 FY2024Mar 31, 2024$195.00K–
Q4 FY2023Dec 31, 2023$4.25M+2.3%
Q3 FY2023Sep 30, 2023$4.14M+28.6%
Q2 FY2023Jun 30, 2023$2.28M-56.7%
Q1 FY2023Mar 31, 2023-$468.00K-112.0%
Q4 FY2022Dec 31, 2022$4.16M+24.5%
Q3 FY2022Sep 30, 2022$3.22M-41.6%
Q2 FY2022Jun 30, 2022$5.26M-11.9%
Q1 FY2022Mar 31, 2022$3.90M+55.2%
Q4 FY2021Dec 31, 2021$3.34M-54.8%
Q3 FY2021Sep 30, 2021$5.52M-32.9%
Q2 FY2021Jun 30, 2021$5.97M+67.9%
Q1 FY2021Mar 31, 2021$2.51M+8875.0%
Q4 FY2020Dec 31, 2020$7.38M+160.9%
Q3 FY2020Sep 30, 2020$8.22M+100.6%
Q2 FY2020Jun 30, 2020$3.55M-43.5%
Q1 FY2020Mar 31, 2020$28.00K–
Q4 FY2019Dec 31, 2019$2.83M-61.9%
Q3 FY2019Sep 30, 2019$4.10M+158.4%
Q2 FY2019Jun 30, 2019$6.29M+189.7%
Q1 FY2019Mar 31, 2019-$2.27M–
Q4 FY2018Dec 31, 2018$7.42M+17.0%
Q3 FY2018Sep 30, 2018$1.59M-18.0%
Q2 FY2018Jun 30, 2018$2.17M+20.9%
Q1 FY2018Mar 31, 2018-$67.00K–
Q4 FY2017Dec 31, 2017$6.34M-42.4%
Q3 FY2017Sep 30, 2017$1.94M-5.9%
Q2 FY2017Jun 30, 2017$1.80M–
Q1 FY2017Mar 31, 2017-$2.46M–
Q4 FY2016Dec 31, 2016$11.00M–
Q3 FY2016Sep 30, 2016$2.06M–

More InfuSystem figures

See a number that looks wrong?